Nebulized nitric oxide/nucleophile adduct reduces pulmonary vascular resistance in mechanically ventilated septicemic sheep

Critical Care Medicine

Volumn 33, Issue 3, 2005, Pages 616-622

  Bjertnaes, Lars J ^a,b   McGuire, Roy ^b   Jodoin, Jeffery ^b   Salzman, Andrew L ^c   Traber, Lillian D ^b   Passerini, Daniel J ^c   Smith, Daniel J ^c   Szabo, Csaba ^c   Traber, Daniel L ^b  

^a UNIVERSITY OF TROMSØ   (Norway)

^b University of Texas Medical Branch School of Medicine   (United States)

^c Inotek Inc   (United States)

Author keywords

Hemodynamics; Mechanical ventilation; Nitric oxide; Pulmonary hypertension; Sepsis; Vascular resistance

Indexed keywords

METHYL N 2 DIMETHYLAMINOETHYL 3 AMINOPROPIONID NITRIC OXIDE; NITRATE; NITRIC OXIDE; NITRIC OXIDE DONOR; NITRITE; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

AEROSOL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ARTIFICIAL VENTILATION; BACTERIUM; BLOOD LEVEL; BODY WEIGHT; CONTROLLED STUDY; DRUG EFFECT; DRUG SOLUBILITY; EXPERIMENT; GAS EXCHANGE; HEALTH CENTER; HEART INDEX; HEMODYNAMICS; INFUSION; INSTRUMENTATION; INTENSIVE CARE UNIT; LUNG ARTERY PRESSURE; LUNG HEMODYNAMICS; LUNG VASCULAR RESISTANCE; MEAN ARTERIAL PRESSURE; MEASUREMENT; NEBULIZATION; NEBULIZER; NONHUMAN; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSEUDOMONAS AERUGINOSA; PULMONARY HYPERTENSION; RANDOMIZATION; REGISTER; SEPSIS; SEPTICEMIA; SHEEP; SYSTEMIC VASCULAR RESISTANCE; TIME; TRACHEOTOMY; UNIVERSITY; WAKEFULNESS;

AEROSOLS; ANIMALS; DIMETHYLAMINES; FEMALE; HEMODYNAMIC PROCESSES; NITRIC OXIDE; NITRIC OXIDE DONORS; PROSPECTIVE STUDIES; PULMONARY GAS EXCHANGE; RANDOM ALLOCATION; RESPIRATION, ARTIFICIAL; SEPSIS; SHEEP; VASCULAR RESISTANCE;

EID: 14944360203     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000156282.22495.A1     Document Type: Article

References (36)

1. Zapol WM, Snider MT: Pulmonary hypertension in severe acute respiratory failure. New Engl J Med 1977; 296:476-480
2. Kraft P, Fridrich P, Fitzgerald RD, et al: Effectiveness of nitric oxide inhalation in septic ARDS. Chest 1996; 109:486-493
3. Dellinger RP, Zimmermann JL, Taylor RW, et al: Effects of inhaled nitric oxide in patients with acute respiratory distress syndrome: Results of a randomized phase II trial. Crit Care Med 1998; 26:15-23
4. Lundin S, Mang H, Smithies M, et al: Inhalation of nitric oxide in acute lung injury: Results of a European multicentre study. The European Study Group of Inhaled Nitric Oxide. Intensive Care Med 1999; 25:911-919
5. Taylor RW, Zimmerman JL, Dellinger RP, et al: Low-dose inhaled nitric oxide in patients with acute lung injury: A randomized controlled trial. JAMA 2004; 291:1603-1609
6. Clark RH, Kueser TJ, Walker MW, et al: Low-dose nitric oxide therapy for persistent pulmonary hypertension of the newborn. Clinical Inhaled Nitric Oxide Research Group. N Engl J Med 2000; 342:469-474
7. Vonbank K, Ziesche R, Higenbottam TW, et al: Controlled prospective randomised trial on the effects on pulmonary haemodynamics of the ambulatory long term use of nitric oxide and oxygen in patients with severe COPD. Thorax 2003; 58:289-293
8. Rajek A, Pernerstorfer T, Kastner J, et al: Inhaled nitric oxide reduces pulmonary vascular resistance more than prostaglandin E(1) during heart transplantation. Anesth Analg 2000; 90:523-530
9. Bone HG, Schenarts PJ, Fischer SR, et al: Pyridoxalated hemoglobin polyoxyethylene conjugate reverses hyperdynamic circulation in septic sheep. J Appl Physiol 1998; 84:1991-1999
10. Dyar O, Young JD, Xiong L, et al: Dose-response relationship for inhaled nitric oxide in experimental pulmonary hypertension in sheep. Br J Anaesth 1993; 71:702-708
11. Bjertnaes LJ, Koizumi T, Newman J: Nitric oxide reduces fluid filtration in awake endotoxemic sheep. Am J Respir Crit Care Med 1998; 158:1416-1423
12. Hinder F, Stubbe HD, Van Aken H, et al: Role of nitric oxide in sepsis-associated pulmonary edema. Am J Respir Crit Care Med 1999; 159:252-257
13. Stubbe HD, Westphal M, Van Aken H, et al: Inhaled nitric oxide reduces lung edema during fluid resuscitation in ovine acute lung injury. Intensive Care Med 2003; 29:1790-1797
14. Beckman JS, Koppenol WH: Nitric oxide, superoxide and peroxynitrite: The good, the bad, and the ugly. Am J Physiol 1996; 271(Cell Physiol 40):C1424-C1437
15. Liaudet L, Soriano FG, Szabo C: Biology of nitric oxide signaling. Crit Care Med 2000; 28:N37-N52
16. Lavoie A, Hall JB, Olson DM, et al: Life-threatening effects of discontinuing inhaled nitric oxide in severe respiratory failure. Am J Respir Crit Care Med 1996; 153:1985-1987
17. Zapol WM, Rimar S, Gillis N, et al: Nitric oxide and the lung. Am J Respir Crit Care Med 1994; 149:1375-1380
18. Ivy DD, Parker D, Doran A, et al: Acute hemodynamic effects and home therapy using a novel pulsed nasal nitric oxide delivery system in children and young adults with pulmonary hypertension. Am J Cardiol 2003; 92:886-890
19. 2N[N(O)NO: O-functionalization chemistry. J Org Chem 1992; 57:6134-6138
20. Morley D, Keefer LK: Nitric oxide/nucleophile complexes: A unique class of nitric oxide-based vasodilators. J Cardiovasc Pharmacol 1993; 22(suppl 7):S3-S9
21. Brilli R, Krafte-Jacobs B, Smith D, et al: Intratracheal instillation of a novel NO/nucleophile adduct selectively reduces pulmonary hypertension. J Appl Physiol 1997; 83:1968-1975
22. Brilli RJ, Krafte-Jacobs B, Smith DJ, et al: Aerosolization of novel nitric oxide donors selectively reduces pulmonary hypertension. Crit Care Med 1998; 26:1390-1396
23. Jacobs BR, Brilli RJ, Ballard ET, et al: Aerosolized soluble nitric oxide donor improves oxygenation and pulmonary hypertension in acute lung injury. Am J Respir Crit Care Med 1998; 158:1536-1542
24. Lam CF, van Heerden PV, Ilett KF, et al: Two aerosolized nitric oxide adducts as selective pulmonary vasodilators for acute pulmonary hypertension. Chest 2003; 123:869-874
25. Kirov MY, Evgenov OV, Kuklin VN, et al: Aerosolized nitric oxide donor DS-1 reduces pulmonary hypertension and edema in endotoxemic sheep. Am J Respir Crit Care Med 2002; 166:1436-1442
26. Barer GR, Howard P, Shaw JW: Stimulus-response curves for the pulmonary vascular bed to hypoxia and hypercapnia. J Physiol 1970; 211:139-155
27. Adrie C, Ichionese F, Holzmann A, et al: Pulmonary vasodilation by nitric oxide gas and prodrug aerosols in acute pulmonary hypertension. J Appl Physiol 1998; 84:435-441
28. Krafte-Jacobs B, Brilli R, Szabo C, et al: Circulating methemoglobin and nitrite/nitrate concentrations as indicators of nitric oxide overproduction in critically ill children with septic shock. Crit Care Med 1997; 25:1588-1593
29. 2 exposure on alveolar permeability and glutathione peroxidase in healthy humans. Am Rev Respir Dis 1992; 146:654-659
30. Davidson CA, Kaminski PM, Wu M, et al: Nitrogen dioxide causes pulmonary arterial relaxation via thiol nitrosation and NO formation. Am J Physiol Heart Circ Physiol 1996; 270:H1038-H1043
31. Nishimura MD, Hess RM, Kacmarek R, et al: Nitrogen dioxide production during mechanical ventilation with nitric oxide in adults. Anesthesiology 1995; 82:1246-1254
32. Januszkiewicz AJ, Mayorga MA: Nitrogen dioxide-induced acute lung injury in sheep. Toxicology 1994; 89:279-300
33. Benzing A, Mols G, Guttmann J, et al: Effect of different doses of inhaled nitric oxide on pulmonary capillary pressure and on longitudinal distribution of pulmonary vascular resistance in ARDS. Br J Anaesth 1998; 80: 440-446
34. Losa M, Tibballs J, Carter B, et al: Generation of nitrogen dioxide during nitric oxide therapy and mechanical ventilation of children with a Servo 900C ventilator. Intensive Care Med 1997; 23:450-455
35. Miller OI, Tang SF, Keech A, et al: Inhaled nitric oxide and prevention of pulmonary hypertension after congenital heart surgery: A randomised double-blind study. Lancet 2000; 356:1464-1469
36. Schreiber MD, Gin-Mestan K, Marks JD, et al: Inhaled nitric oxide in premature infants with the respiratory distress syndrome. N Engl J Med 2003; 349:2099-2107